Where next for prophylaxis against pre-eclampsia?: Participants at the workshop include

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 7, 1996, Pages 603-607

  Pipkin, F Broughton ^a   Crowther, C ^b   de Swiet, M ^c   Duley, L ^d   Judd, A ^e   Lilford, R J ^f   Onwude, J ^g   Prentice, C ^h   Redman, C W G ⁱ   Roberts, J ^j   Thornton, J ^h   Walker, J ^h  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Leeds General Hospital   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g Chelmsford   (United Kingdom)

^h UNIVERSITY OF LEEDS   (United Kingdom)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; CALCIUM; CORTICOSTEROID;

CONFERENCE PAPER; DRUG EFFICACY; FEMALE; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROPHYLAXIS;

ASPIRIN; CALCIUM; FEMALE; FISH OILS; HUMANS; PLANT OILS; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY;

EID: 0029900997     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09824.x     Document Type: Article

References (43)

1. Collins R. Antiplatelet agents for IUGR and pre-eclampsia. In Enkin M, Keirse MJ, Renfrew M, Neilson, JP, editors. Pregnancy and Childbirth Module. Cochrane Database of Systematic Reviews, Review Number 04000, 1994.
2. de Swiet M, Fryers G. The use of aspirin in pregnancy. J Obstet Gynaecol 1990; 10: 467–482.
3. Sibai BM, Cartitis SN, Thom E et al. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329: 1213–1218.
4. Italian Study of Aspirin in Pregnancy. Low dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy induced hypertension. Lancet 1993; 341: 396–400.
5. Hauth JC, Goldenberg RL, Parker CR Jr et al. Low dose aspirin therapy to prevent pre-eclampsia. Am J Obstet Gynecol 1993; 166: 1083–1093.
6. Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1–3.
7. CLASP (Collaborative Low Dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619–629.
8. Beilin L. Aspirin and pre-eclampsia: aspirin should not be used routinely to prevent or treat pre-eclampsia. BMJ 1994; 308: 1250–1251.
9. McParland P, Pearce JM, Chamberlain GVP. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990; 335: 1552–1555.
10. Darling M, Higgins J. CLASP: millstone or milestone Lancer 1994; 343: 616–617.
11. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341: 1447–1451.
12. ECPPA Collaborative Group. ECPPA: a randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk asymptomatic pregnancies. Br J Obstet Gynaecol 1996; 103: 39–47.
13. Robillard P-Y, Hulsey TC, Pdrianin J, Janky E, Miri EH, Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344: 973–975.
14. Benigni A, Gregorini G, Frasca T. Effect of low dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk of pregnancy induced hypertension. N Engl J Med 1989; 321: 357–362.
15. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; 1: 840–842.
16. Uzan S, Beaufils M, Breart G, Bazic B, Capitant C, Paris J. Prevention of fetal growth retardation with low dose aspirin: findings of the EPREDAL trial. Lancet 1991; 337: 1427–1431.
17. Kitsis EA, Weissman G, Abramson SB. The prostaglandin paradox—additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin-E, analog misoprostol. J Rheumatol 1991; 18: 1461–1465.
18. Abramson SB, Leszczynskapiziak J, Clancy RM, Philips M, Weissman G. Inhibition of neutrophil function by aspirin-like drugs (NSAIDS)—requirement for assembly of heterotrimeric G-proteins in bilayer phospholipid. Biochem Pharrn 1994; 47: 563–572.
19. Andrews FJ, Malcontenti-Wilson C, O'Brien PE. Effect of non-steroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am J Physiol 1994; 266: G657–G664.
20. Minikami K, Watanabe Y, Miahara M, Konucki H, Kurashige T, Utsumi K. Effect of indomethacin and aspirin on the TNF-alpha-induced priming and protein tyrosyl phosphorylation of human neutrophils. Physiol Chem Physics Med NMR 1993; 25: 55–61.
21. Belizan JM, Villar J. The relationship between calcium intake and edema, proteinuria, and hypertension-gestosis: an hypothesis. Am J Clin Nutr 1980; 33: 2202–2210.
22. Hamlin RHJ. The prevention of eclampsia and pre-eclampsia. Lancer 1952; 1: 64–68.
23. Carroli G, Duley L, Belizan JM and Villar J. Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. Er J Obstet Gynaecol 1994; 101: 753–758.
24. Belizan JM, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991; 325: 1399–1405.
25. August P, Marcaccio B, Gartner JM, Druzin ML, Resnick LM, Laragh JH. Abnormal 1,25-dihydroxyvitamin D metabolism in pre-eclampsia. Am J Obstet Gynecol 1992; 166: 1295–1299.
26. Goodnight SH, Harris WS, Connor WE. Effect of dietary w-3 fatty acids on platelet composition and function in man: a prospective study. Blood 1981; 58: 881–885.
27. Lorenz R, Spengler U, Fuscher S, Duhm J, Weber PC. Platelet function, thromboxane formation and blood pressure control during supplementation of the western diet with codliver oil. Circulation 1983; 67: 504–511.
28. Mortensen JZ, Schmidt EB, Nielsen AH, Dyerberg J. The effect of n-6 and n-3 polyunsaturated fatty acids on haemostasis, blood lipids and blood pressure. Thromb Haemostm 1983; 50: 543–546.
29. Singer P, Wirth M, Voigt S et al. Blood pressure- and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. Atherosclerosis 1985; 56: 223–235.
30. People's League of Health. The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity. J Obstet Gynaecol Er Emp 1946; 53: 498–509.
31. Olsen SF, Hansen HS, Jensen B. Fish oil versus arachis oil food supplementation in relation to pregnancy duration in rats. Prostaglandins, Leukotrienes and Essential Fatty Acids 1990; 40: 255–260.
32. Olsen S, Sorensen JD, Secher NL et al. Randomised controlled trial of effect of fish oil supplementation on pregnancy duration. Lancet 1992; 339: 1003–1007.
33. Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D. A randomised double-blind placeboantrolled trial of fish oil in high risk pregnancy. Er J Obstet Gynaecol 1995; 102: 95–100.
34. Bulstra-Ramatiers MTE, Huisjes HJ, Visser GHA. The effects of 3 g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Er J Obstet Gynaecol 1995; 102: 123–126.
35. Tobin D. Fish oil supplementation in pregnancy. Lancet 1992; 340: 118.
36. Broughton, Pipkin F, Morrison RA, O'Brien PMS. The effect of dietary supplementation with linoleic acids and the pressor and biochemic response to exogenous angiotensin 11 in human pregnancy. Prog Lipid Res 1986; 25: 425–429.
37. D'Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic and docahexaen oil acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women and Health 1992; 19: 117–131.
38. Hubel CA, Roberts JM, Taylor RN, Musci TJ Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on pre-eclampsia. Am J Obsfet Gynecol 1989; 161: 1025–1034.
39. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EM BO Journal (Oxford) 1991; 10: 2247–2258.
40. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, anti-oxidants, and human disease: where are we now J Lab Clin Med 1992; 119: 598–620.
41. Halliwell B. Vitamin C: the key to health or slow acting carcinogen Redox Report 1994; 1: 5–9.
42. Stark JM. Pre-eclampsia and cytokine induced oxidative stress. Br J Obstet Gynaecol 1993; 100: 105–109.
43. Australasian Society for the Study of Hypertension in Pregnancy. Aspirin and prevention of pre-eclampsia. Aust N Z J Obstet Gynaecol 1995; 35: 38–41.